Clinical Trial Update: Pharmacokinetics (PK) Study of AC480 for Recurrent Glioma [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study of AC480 for recurrent glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• AC480

Snippet

Sponsor: Annick Desjardins | Conditions: Glioma | Phase 1 | Status: COMPLETED